Oxaliplatin-induced haematological toxicity and splenomegaly in mice

PURPOSE: Haematological toxicities occur in patients receiving oxaliplatin. Mild anaemia (grade 1–2) is a common side effect and approximately 90% of recipients develop measurable spleen enlargement. Although generally asymptomatic, oxaliplatin-induced splenomegaly is independently associated with c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lees, Justin G., White, Daniel, Keating, Brooke A., Barkl-Luke, Mallory E., Makker, Preet G. S., Goldstein, David, Moalem-Taylor, Gila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467301/
https://www.ncbi.nlm.nih.gov/pubmed/32877416
http://dx.doi.org/10.1371/journal.pone.0238164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467301/
https://www.ncbi.nlm.nih.gov/pubmed/32877416
http://dx.doi.org/10.1371/journal.pone.0238164

Ejemplares similares